We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.6B
AUM Growth
+$2.03B
Cap. Flow
+$1.28B
Cap. Flow %
5.2%
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$167M
2
AAPL icon
Apple
AAPL
+$66M
3
MSFT icon
Microsoft
MSFT
+$57.3M
4
HDB icon
HDFC Bank
HDB
+$44M
5
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$41.9M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$81.5M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$81.3M
3
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$45.8M
4
AMD icon
Advanced Micro Devices
AMD
+$43.4M
5
META icon
Meta Platforms (Facebook)
META
+$35M

Sector Composition

Rank Sector Weight
1 Technology 33.15%
2 Consumer Discretionary 10.25%
3 Communication Services 8.94%
4 Healthcare 6.61%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRVS icon
1501
Corvus Pharmaceuticals
CRVS
$1.27B
$11.2K ﹤0.01%
+2,141
New +$16K
SLN
1502
Silence Therapeutics
SLN
$658M
$11.1K ﹤0.01%
+1,566
New +$20.2K
VIRT icon
1503
Virtu Financial
VIRT
$5.06B
$11.1K ﹤0.01%
311
-63
-17% -$2.17K
BAK icon
1504
Braskem
BAK
$837M
$11.1K ﹤0.01%
2,912
-100
-3% -$552
SVC
1505
Service Properties Trust
SVC
$1.07B
$11K ﹤0.01%
880
-407
-32% -$6.58K
TRVI icon
1506
Trevi Therapeutics
TRVI
$2.61B
$10.9K ﹤0.01%
+2,561
New +$8.2K
SLRN
1507
DELISTED
ACELYRIN
SLRN
$10.9K ﹤0.01%
3,343
-267
-7% -$1.29K
LLYVK icon
1508
Liberty Live Group Series C
LLYVK
$9.88B
$10.8K ﹤0.01%
156
-94
-38% -$5.97K
RVNC
1509
DELISTED
Revance Therapeutics, Inc.
RVNC
$10.7K ﹤0.01%
3,496
-295
-8% -$1.28K
AQST icon
1510
Aquestive Therapeutics
AQST
$537M
$10.7K ﹤0.01%
+3,038
New +$14K
ABSI icon
1511
Absci
ABSI
$1.63B
$10.6K ﹤0.01%
+3,827
New +$13.5K
HPP
1512
Hudson Pacific Properties
HPP
$789M
$10.5K ﹤0.01%
507
-197
-28% -$5.38K
VYGR icon
1513
Voyager Therapeutics
VYGR
$201M
$10.4K ﹤0.01%
1,820
-152
-8% -$980
CBL
1514
CBL Properties
CBL
$1.78B
$10.2K ﹤0.01%
343
-152
-31% -$4.31K
DHC
1515
Diversified Healthcare Trust
DHC
$2.02B
$10.2K ﹤0.01%
4,699
-1,839
-28% -$5.41K
LAND
1516
Gladstone Land Corp
LAND
$358M
$10.1K ﹤0.01%
950
-371
-28% -$4.6K
RIGL icon
1517
Rigel Pharmaceuticals
RIGL
$761M
$9.69K ﹤0.01%
+587
New +$11.3K
ZG icon
1518
Zillow
ZG
$8.09B
$9.67K ﹤0.01%
133
-80
-38% -$5.51K
AVIR icon
1519
Atea Pharmaceuticals
AVIR
$410M
$9.37K ﹤0.01%
2,815
-238
-8% -$791
VNDA icon
1520
Vanda Pharmaceuticals
VNDA
$305M
$9.35K ﹤0.01%
1,943
-165
-8% -$792
LXRX icon
1521
Lexicon Pharmaceuticals
LXRX
$1.05B
$9.32K ﹤0.01%
12,046
-1,028
-8% -$1.24K
GOTU icon
1522
Gaotu Techedu
GOTU
$398M
$9.16K ﹤0.01%
4,241
-135
-3% -$393
LMND icon
1523
Lemonade
LMND
$4.09B
$9.02K ﹤0.01%
246
-39
-14% -$1.25K
ACIU icon
1524
AC Immune
ACIU
$265M
$9K ﹤0.01%
3,296
-281
-8% -$878
FHTX icon
1525
Foghorn Therapeutics
FHTX
$393M
$8.93K ﹤0.01%
+1,853
New +$13.5K
59 60
61
62 63

Similar funds

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Mirae Asset Global Investments's Q4 2024 Portfolio in Review

As of Q4 2024, Mirae Asset Global Investments held 1,702 positions worth $24.6B, up 9% from $22.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mirae Asset Global Investments deployed $1.28B of net new capital in Q4 2024, opening 151 new positions and adding to 731 existing holdings. Its largest new stake was Strategy Inc: 36,162 shares worth $11.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $81.5M trimmed.

  • Mirae Asset Global Investments's largest Q4 2024 buy was Strategy Inc: 36,162 shares worth $11.8M.
  • Mirae Asset Global Investments added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $167M increase.
  • Mirae Asset Global Investments's biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $81.5M.
  • Mirae Asset Global Investments fully exited VanEck Pharmaceutical ETF in Q4 2024, selling an estimated $23.6M.
  • Mirae Asset Global Investments's ten largest holdings make up 38% of its $24.6B portfolio in Q4 2024.
  • Mirae Asset Global Investments opened 151 new positions and closed 110 in Q4 2024.
  • Mirae Asset Global Investments's portfolio value rose 9% quarter-over-quarter to $24.6B.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.